UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030149
Receipt number R000034367
Scientific Title Development of a method of Caring in Nursing for the Elderly in Cooperation with a Caring Nurse Robot
Date of disclosure of the study information 2017/12/15
Last modified on 2017/11/27 15:11:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of a method of Caring in Nursing for the Elderly in Cooperation with a Caring Nurse Robot

Acronym

Development of a method of Nursing with a Caring Nurse Robot

Scientific Title

Development of a method of Caring in Nursing for the Elderly in Cooperation with a Caring Nurse Robot

Scientific Title:Acronym

Development of a method of Nursing with a Caring Nurse Robot

Region

Japan


Condition

Condition

Mild dementia

Classification by specialty

Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study consider how to practice nursing as a caring for dementia patients based on the Transactive Relationship Theory of Nursing (TRETON) which developed by Dr. Tanioka, a research director who presented a new relationship between Caring Nurse Robot (CNR) and patients, healthcare providers (nurses, care workers, etc.), and older adults with dementia. This clarifies necessary nursing functions in the transactive relations. Also, clarify the nursing methodology (effects, ethical issues, improvement points, etc.) as a caring in nursing by TRETON when practical use of CNR.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

(1) Sensory evaluation
Evaluate the mood, impression, satisfaction when talking with CNR which improved Pepper.
(2) Verification test
Evaluate the autonomic nervous activity (HF, LF / HF), sleep efficiency, sleeping time, acceleration, activity amount obtained from Actigraph, range of joint motion of upper and lower limbs, isometric muscle strength.

Key secondary outcomes

(1) Sensory evaluation
Analysis of evaluation items by free description


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

1) Natural language dialogue (NLD) program is created in which older adults with dementia can feel enjoy and uplifting. Also, considering ethical issues related to clinical use of caring nurse robot (Sensory evaluation 1).
2) Clarify the function of nursing as caring by TRETON which necessary for CNR. Also prepare a varification test and pre-test of created NLD program (Sensory evaluation 2, Verification test 1,2).
3) CNR with improved Pepper (RP - CNR) is used in the clinical setting. This stage will continue to consider ethical issues. Then, we modify the program based on the verification test (Sensory evaluation 3, Verification test 3). We clarify the necessary nursing functions for healthy elderly people and elderly people with dementia from the database for the RP - CNR obtained in the second and third stages. Also develop an interface for sharing information among the RP-CNR, nurses and other healthcare providers.
4) The RP-CNR will be improved for clinical use and put to practical use.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

95 years-old >

Gender

Male and Female

Key inclusion criteria

Person who can conduct interpersonal conversation

1. Sensory evaluation 1
(1)120 healthy people who participated in the summer festival at Mifune Hospital
(2) Age ranges 20 - 95
2. Sensory evaluation 2
(1) Healthcare providers working at Mifune Hospital, Fukujyu-sou (120 people)
(2) Age ranges 20 - 65
(3) Those who can measure their blood pressure by themselves and show them to CNR who has improved Pepper
3. Sensory evaluation 3
(1) 120 people including inpatients at Miho Hospital's dementia treatment hospital, residents of Fukujyu-sou, day service users, etc.
(2) Age ranges 65 - 95
(3) Those who can measure blood pressure by hand through an automatic sphygmomanometer and show it to CNR with improved Pepper
4. Verification test 1, 2, 3
1) 90 elderly men and women who have moved to Fukujyu-sou and are undergoing diagnosis of dementia satisfying the following conditions (30 people, 3 times)
(1) Degree of dementia revised Hasegawa formula simple intelligence evaluation scale (HDS - R) 5 - 15 points
(2) Those who can simultaneously measure Actigraph and heart rate variability
(3) Age ranges 70 - 95
2) Healthy adult male and female 90 people (30 people, 3 times) satisfying the following conditions
(1) Nonsmokers who can refrain from alcohol intake during the research cooperation period, and medical workers
(2) People without heart disease
(3) Those who can simultaneously measure Actigraph and heart rate variability
(4) Age ranges 20 - 65
3) 90 healthy elderly men and women with the following conditions (30 people, 3 times)
(1) Those who are non-smokers and who can refrain from alcohol intake during the research cooperation period
(2) People without heart disease
(3) Those who can simultaneously measure Actigraph and heart rate variability
(4) Age ranges 65 - 95

Key exclusion criteria

1. Sensory evaluation 1, 2
Nothing special
2. Sensory evaluation 3
Those who are severely demented and have a lack of conversation and judgment

3. Verification test 1, 2, 3
(1) Those with heart disease are excluded from the subject because they affect the analysis of balance of autonomic nervous activity. However, person with hypertension can include in the subject.
(2) Those who are likely to cause skin symptoms (itching, redness, etc.) on electrode seals and Actigraph for measuring heart rate variability are excluded.
(3) Those taking sleep inducing agents or anxiolytic agents. However, those who are judged by the physician which medicine do not to affect the intervention of this survey can include.

Target sample size

630


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tetsuya Tanioka

Organization

Tokushima University

Division name

Department of Nursing Outcome Management,Institute of Biomedical Sciences

Zip code


Address

18-15 Kuramoto-cho 3 Tokushima, 770-8509, Japan

TEL

088-633-9021

Email

tanioka.tetsuya@tokushima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tetsuya Tanioka

Organization

Tokushima University

Division name

Department of Nursing Outcome Management,Institute of Biomedical Sciences

Zip code


Address

18-15 Kuramoto-cho 3 Tokushima, 770-8509, Japan

TEL

088-633-9021

Homepage URL


Email

tanioka.tetsuya@tokushima-u.ac.jp


Sponsor or person

Institute

Tokushima University

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research (FY2017)<KAKENHI>

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

三船病院(香川県)、介護老人保健施設福寿荘(香川県)/ Mifune Hospital(Kagawa), Fukujusou(Kagawa)


Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2018 Year 01 Month 10 Day

Date of IRB


Anticipated trial start date

2018 Year 01 Month 10 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 11 Month 28 Day

Last modified on

2017 Year 11 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034367


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name